drugset / Trial / NCT05542173

Efficacy and Safety of BALI Association in the Treatment of Aphthous Ulcerations

NCT05542173 ↗

Phase 3 Unknown 232 enrolled EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of BALI association in the treatment of aphthous ulceration.

Timeline

Start
2024-09
Primary completion
2025-09
Completion
2025-09

Drugs

EvaluationDrugModalityDoseRoute
Subject BALI association Unknown 15 mg Oral
Subject BALI association Unknown 25 mg Oral

Indications